Could a simple Chest-and-Arm patch replace bulky heart monitors?

NCT ID NCT07694570

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests a new wearable system called M2VS that measures heart activity (ECG) and blood pressure continuously for 24 hours. Researchers want to see if it works as well as standard monitors like Holter ECG and ambulatory blood pressure monitors. The study involves 20 adults with atrial fibrillation or hypertension who already need 24-hour monitoring. The goal is to check how reliable and comfortable the M2VS system is compared to current devices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
M2VS system (wearable sensor with belt)
What this could lead to
If successful, this could lead to more comfortable and convenient ways to monitor heart rhythm and blood pressure continuously during daily life.
What could go wrong
This is a small feasibility study (20 participants) focused on data quality and comfort, not on treating or diagnosing disease. The device may not prove accurate enough to replace standard monitors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Basel

    Basel, Canton of Basel-City, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.